Search Results - camila+gadens+zamboni

1 Results

Sort By:

Transcriptionally Targeted and CPG-free Plasmid for Theranostic Gene Therapy

Unmet NeedHepatocellular carcinoma (HCC) is the third leading cancer in the US with a ~twenty percent (20%) survival rate. HCC develops typically in the inflammatory environment of the liver caused by infections or liver disease. Therefore, it is essential to have highly targeted anti-cancer therapies to achieve clinical efficacy. Currently, viral gene...

Published: 6/27/2024 | Inventor(s): Jordan Green, Martin Pomper, Camila Gadens Zamboni, Hannah Vaughan, Il Minn

Keywords(s): Biologics, Cancers, Disease Indication, Gene Therapy, Hepatocellular Carcinoma, Liver Cancer, Nucleic Acid, Single, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type

Category(s): Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Biologics, Clinical and Disease Specializations > Oncology > Hepatocellular Carcinoma